These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3796910

  • 1. Uterine papillary serous carcinoma.
    Chambers JT, Merino M, Kohorn EI, Peschel RE, Schwartz PE.
    Obstet Gynecol; 1987 Jan; 69(1):109-13. PubMed ID: 3796910
    [Abstract] [Full Text] [Related]

  • 2. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE.
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
    Ren YL, Wang HY, Shen L, Yang WT.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):817-21. PubMed ID: 17327111
    [Abstract] [Full Text] [Related]

  • 4. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A, Rare Cancer Network.
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [Abstract] [Full Text] [Related]

  • 5. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE.
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS, Wong EH, Tan HS, Yap SP, Chua EJ, Sethi VK, Soh LT, Low J, Tay EH, Chew SH.
    Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
    [Abstract] [Full Text] [Related]

  • 7. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W, DO V, Hogg R, Wain G, Brand A, Bull C, Stenlake A, Gebski V.
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [Abstract] [Full Text] [Related]

  • 8. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC, Seidman JD, McBroom JW, MacKoul PJ, Aye LM, Rose GS.
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [Abstract] [Full Text] [Related]

  • 9. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE, Asrari F, Trimble EL, Montz FJ.
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS, Modesitt SC, DePriest PD, Ueland FR, Wilder J, Reedy MB, Pavlik EJ, Kryscio R, Cibull M, Giesler J, Manahan K, Huh W, Cohn D, Powell M, Slomovitz B, Higgins RV, Merritt W, Hunter J, Puls L, Gehrig P, van Nagell JR.
    Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
    [Abstract] [Full Text] [Related]

  • 11. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL, Manetta A, Alvarez RD, Williams L, Creasman WT.
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [Abstract] [Full Text] [Related]

  • 16. Magnetic resonance imaging in stage I endometrial carcinoma.
    Chen SS, Rumancik WM, Spiegel G.
    Obstet Gynecol; 1990 Feb; 75(2):274-7. PubMed ID: 2300356
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A, Landoni F, Sartori E, Maggino T, Zola P, Gabriele A, Rossi R, Cosio S, Fanucchi A, Tisi G.
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Surgical and radiologic treatment of cancer of the uterine body. Results of 12 years].
    Di Pietrantonj F, Proietti A, Cardinali M, Fabbietti L, Di Furia L, Giulioni M.
    Minerva Med; 1993 Nov; 84(11):603-14. PubMed ID: 8015688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.